Ticker Details
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
IPO Date:	May 11, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.09B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.26 | 2.99%
Avg Daily Range (30 D):	$0.40 | 2.81%
Avg Daily Range (90 D):	$0.44 | 3.61%

Institutional Daily Volume
Avg Daily Volume:	.94M
Avg Daily Volume (30 D):	1.59M
Avg Daily Volume (90 D):	2.14M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	70
Avg Trade Size (Sh.) (90 D):	82

Institutional Trades
Total Institutional Trades:	5,845
Avg Institutional Trade:	$3.05M
Avg Institutional Trade (30 D):	$2.51M
Avg Institutional Trade (90 D):	$2.79M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.86M
Avg Closing Trade (30 D):	$3.78M
Avg Closing Trade (90 D):	$4.38M
Avg Closing Volume:	136.19K

News

Mar 23, 2026 @ 5:17 PM Biohaven Stock Down 70% but One Fund's New $6 Mill... Source: Jonathan Ponciano

Jan 15, 2026 @ 2:48 AM Biohaven (BHVN) Stock Is Trending Overnight â€â... Source: Mohd Haider

Dec 26, 2025 @ 2:26 PM Stock Market Today: Dow Jones, S&P 500, Nasdaq Fut... Source: Rishabh Mishra

Dec 2, 2025 @ 6:00 PM Migraine Clinical Trial Pipeline Expands as 30+ Co... Source: Delveinsight

Nov 19, 2025 @ 10:15 PM Biohaven's Chief Accounting Officer Scooped Up 17,... Source: Robert Izquierdo

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.91	$-.88	$-1.12
Diluted EPS	$-.91	$-.88	$-1.12
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-137.31M	$-130.53M	$-145.56M
Operating Income / Loss	$-124.9M	$-130.43M	$-142.73M
Cost of Revenue
Net Cash Flow	$-36.48M	$44.33M	$44.4M
PE Ratio